- ¥380 - 3800
- 百奥莱博
- M00560-GEA
- 北京
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
91
- 英文名：
GW0742
- CAS号：
317318-84-6
- 保质期：
2年
- 供应商：
北京百奥莱博科技有限公司
- 保存条件：
-20℃，有效期2年，溶入溶剂后-20℃
- 规格：
1mL(10mM)|5mg|10mg|50mg|100mg
特别提示：包括高度PPARδ激动剂(GW0742)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
产品名称：高度PPARδ激动剂(GW0742)
英文名称：GW0742
产品货号：M00560
产品规格：1mL(10mM)|5mg|10mg|50mg|100mg
GW0742(GW610742)是一种有效的高度选择性PPARδ激动剂,作用于PPARδ,-α,和-γ受体，EC50值分别为1nM,1.1μM and2μM。
注：本品仅可用于科研实验，严禁用于临床医疗及其他用途！
CAS号：317318-84-6
别名：GW610742
纯度：99.63%
分子式：C₂₁H₁₇F₄NO₃S₂
分子量：471.49
结构式：
储存条件：-20℃，有效期2年，溶入溶剂后-20℃请尽量在一个月内使用。
除了高度PPARδ激动剂(GW0742),GW610742，我公司还供应以下相关产品：
| 货号 | 名称 | 规格 |
| YT931 | EZH2抑制剂(GSK126) | 10mM×0.2ml|5mg|25mg |
| M00119 | IAP抑制剂(LCL161) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M00220 | PTEN抑制剂 | 1mL(10mM)|5mg|10mg|50mg|100mg|200mg |
| M00271 | LAT1抑制剂(JPH203) | 1mL(10mM)|2mg|5mg|10mg|25mg|50mg|100mg |
| M00527 | RSK2抑制剂(CMK) | 1mL(10mM)|2mg|5mg|10mg|25mg |
| M00679 | Chk1抑制剂(CHIR-124) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M00943 | HDAC、EGFR和HER2抑制剂(CUDC-101) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M01561 | ALK5抑制剂(R-268712) | 1mL(10mM)|2mg|5mg|10mg|50mg|100mg |
| M01650 | HDAC I型抑制剂(BG45) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M01736 | TNKS1/2抑制剂(AZ6102) | 1mL(10mM)|2mg|5mg|10mg|25mg|50mg|100mg |
| M01957 | 核苷酸逆转录酶抑制剂(Tenofovir Disoproxil) | 1mL(10mM)|10mg|50mg|100mg|200mg|500mg |
| M02087 | MEK抑制剂（Cobimetinib hemifumarate） | 1mL(10mM)|2mg|5mg|10mg|50mg |
| M03072 | 大鼠Nav1.7离子通道抑制剂（ICA-121431） | 1mL(10mM)|10mg|50mg |
| M03518 | HIV-1蛋白酶抑制剂(Tipranavir) | 1mL(10mM)|1mg|5mg|10mg |
| M04373 | NS3/4A蛋白酶抑制剂（Paritaprevir） | 1mL(10mM)|2mg|5mg|10mg|50mg|100mg |
| M04658 | S1P1受体激动剂（Cenerimod） | 1mL(10mM)|2mg|5mg|10mg|50mg|100mg |
| M04747 | MMP-1抑制剂(S-methyl-KE-298) | 1mg |
| M05479 | DGAT-1抑制剂（DGAT-1 inhibitor 2） | 1mL(10mM)|5mg|10mg|50mg |
| M05916 | FGFR4抑制剂(FGFR4-IN-1) | 1mL(10mM)|1mg|5mg|10mg|50mg|100mg |
| M06235 | IL-1β分泌抑制剂(GIBH-130) | 1mL(10mM)|2mg|5mg|10mg|50mg|100mg |
| M06315 | 乙酰胆碱酯酶(AChE)抑制剂和D2DR抑制剂 | 1mL(10mM)|1g|5g |
| M07086 | 前列腺素E2受体激动剂(Taprenepag) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M07142 | 氯离子通道抑制剂 | 1mL(10mM)|10mg|50mg |
| M07287 | α1肾上*素受体激动剂 | 1mL(10mM)|100mg |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验at all the conditions? 2, if the positive control turns out the predict result, it's possible your drug may exert its anti-inflamation effect not through the reported PPAR pathway. and GW9662 can potentiate the other anti-inflamation pathway. So you may want
. A new drug candidate belonging to the family of the peroxisome proliferator-activated receptor-delta agonists termed GW1516 (also referred to as GW501516) has been prohibited by the World Anti-Doping Agency in 2009
PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
and that treatment with a selective PPARβ/δ agonist, GW501516, stimulated the expression of EP4 and induced NSCLC cell proliferation. In addition, this PPARβ/δ agonist also induced EP4 promoter activity through the binding of C/EBP to the NF-IL6 site in the EP
技术资料暂无技术资料 索取技术资料
